Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(1.97)
# 3,032
Out of 4,876 analysts
381
Total ratings
32.81%
Success rate
-6.77%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALT Altimmune | Reiterates: Buy | $12 | $3.50 | +242.86% | 18 | Jun 27, 2025 | |
| ANRO Alto Neuroscience | Reiterates: Buy | $10 | $2.31 | +332.90% | 2 | Jun 26, 2025 | |
| IVVD Invivyd | Reiterates: Buy | $5 | $0.73 | +588.23% | 19 | Jun 26, 2025 | |
| SGMO Sangamo Therapeutics | Reiterates: Buy | $10 | $0.54 | +1,748.77% | 26 | Jun 24, 2025 | |
| SLN Silence Therapeutics | Reiterates: Buy | $75 | $5.79 | +1,195.34% | 24 | Jun 13, 2025 | |
| IMCR Immunocore Holdings | Reiterates: Buy | $100 | $31.15 | +221.03% | 21 | Jun 2, 2025 | |
| QURE uniQure | Reiterates: Buy | $70 | $13.86 | +405.05% | 15 | May 29, 2025 | |
| ONCY Oncolytics Biotech | Reiterates: Buy | $5 | $0.75 | +566.13% | 18 | May 21, 2025 | |
| DTIL Precision BioSciences | Reiterates: Buy | $60 | $4.30 | +1,295.35% | 18 | May 21, 2025 | |
| ATAI Atai Life Sciences | Reiterates: Buy | $10 | $2.20 | +354.55% | 19 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $16.08 | +397.51% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $2.77 | +1,524.55% | 15 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $12.44 | +221.54% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.96 | +913.51% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $70 | $31.98 | +118.89% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $80 | $16.80 | +376.19% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $322.83 | +54.88% | 26 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $10 | $1.86 | +437.63% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.25 | +700.00% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $55 | $6.55 | +739.69% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $5.17 | +2,027.66% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $23.27 | +265.28% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $190 → $150 | $8.15 | +1,740.49% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $170 → $68 | $11.35 | +499.12% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $260 → $340 | $307.96 | +10.40% | 1 | Aug 18, 2021 |
Altimmune
Jun 27, 2025
Reiterates: Buy
Price Target: $12
Current: $3.50
Upside: +242.86%
Alto Neuroscience
Jun 26, 2025
Reiterates: Buy
Price Target: $10
Current: $2.31
Upside: +332.90%
Invivyd
Jun 26, 2025
Reiterates: Buy
Price Target: $5
Current: $0.73
Upside: +588.23%
Sangamo Therapeutics
Jun 24, 2025
Reiterates: Buy
Price Target: $10
Current: $0.54
Upside: +1,748.77%
Silence Therapeutics
Jun 13, 2025
Reiterates: Buy
Price Target: $75
Current: $5.79
Upside: +1,195.34%
Immunocore Holdings
Jun 2, 2025
Reiterates: Buy
Price Target: $100
Current: $31.15
Upside: +221.03%
uniQure
May 29, 2025
Reiterates: Buy
Price Target: $70
Current: $13.86
Upside: +405.05%
Oncolytics Biotech
May 21, 2025
Reiterates: Buy
Price Target: $5
Current: $0.75
Upside: +566.13%
Precision BioSciences
May 21, 2025
Reiterates: Buy
Price Target: $60
Current: $4.30
Upside: +1,295.35%
Atai Life Sciences
May 20, 2025
Reiterates: Buy
Price Target: $10
Current: $2.20
Upside: +354.55%
May 20, 2025
Reiterates: Buy
Price Target: $80
Current: $16.08
Upside: +397.51%
May 12, 2025
Reiterates: Buy
Price Target: $45
Current: $2.77
Upside: +1,524.55%
May 9, 2025
Reiterates: Buy
Price Target: $40
Current: $12.44
Upside: +221.54%
Apr 8, 2025
Reiterates: Buy
Price Target: $30
Current: $2.96
Upside: +913.51%
Apr 8, 2025
Reiterates: Buy
Price Target: $70
Current: $31.98
Upside: +118.89%
Apr 7, 2025
Reiterates: Buy
Price Target: $80
Current: $16.80
Upside: +376.19%
Apr 2, 2025
Reiterates: Buy
Price Target: $500
Current: $322.83
Upside: +54.88%
Apr 1, 2025
Maintains: Buy
Price Target: $25 → $10
Current: $1.86
Upside: +437.63%
Mar 18, 2025
Reiterates: Buy
Price Target: $10
Current: $1.25
Upside: +700.00%
Mar 7, 2025
Reiterates: Buy
Price Target: $55
Current: $6.55
Upside: +739.69%
Feb 28, 2025
Reiterates: Buy
Price Target: $110
Current: $5.17
Upside: +2,027.66%
Feb 19, 2025
Reiterates: Buy
Price Target: $85
Current: $23.27
Upside: +265.28%
Feb 13, 2025
Maintains: Buy
Price Target: $190 → $150
Current: $8.15
Upside: +1,740.49%
Sep 23, 2022
Maintains: Buy
Price Target: $170 → $68
Current: $11.35
Upside: +499.12%
Aug 18, 2021
Maintains: Outperform
Price Target: $260 → $340
Current: $307.96
Upside: +10.40%